secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2025-11-03T23:59:59+00:00
Accession:  0001104659-25-105298
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iradimed reports record Q3 revenue of $21.2M, up 16% YoY; raises FY2025 guidance
--------------------------------------------------------------------------------

- GAAP diluted EPS $0.43, non-GAAP diluted EPS $0.47; net income $5.6M (+10% YoY).
- Full-year 2025 guidance raised: revenue $82.5M-$83.5M, GAAP EPS $1.68-$1.72, non-GAAP EPS $1.84-$1.88.
- Declares quarterly dividend of $0.17/share, payable Nov 25, 2025, record date Nov 14, 2025.
- Next-generation 3870 MRI-compatible IV pump on track for limited commercial shipments Dec 2025, full rollout Q1 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000110465925105298/0001104659-25-105298-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000110465925105298/irmd-20251103x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-105298

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer